SCHEMBL24256009

SCHEMBL24256009

OCC12COC(CC(O)C1O)O2

nearest known ligand 0.42

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ ASGR1 P07306 9/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17286180 1.00 ASGR1 (0.42) ASGR1
SCHEMBL24256104 0.83 — —
SCHEMBL22640970 0.75 ASGR1 (0.37) ASGR1
SCHEMBL16573636 0.69 ASGR1 (0.42) ASGR1
SCHEMBL19574104 0.69 ASGR1 (0.42) ASGR1
SCHEMBL16130851 0.69 ASGR1 (0.42) ASGR1
SCHEMBL30063145 0.68 — —
SCHEMBL24724920 0.68 — —
SCHEMBL21479787 0.67 ASGR1 (0.35) ASGR1
SCHEMBL17286213 0.67 ASGR1 (0.35) ASGR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022235699-A2 POTENT ASGPR-BINDING COMPOUNDS FOR THE DEGRADATION OF IMMUNOGLOBULINS AND OTHER PROTEINS AVILAR THERAPEUTICS, INC. (US) 2022-11-10 — — WO disclosed
WO-2022035997-A1 IN VIVO ASSEMBLY OF ASGPR BINDING THERAPEUTICS AVILAR THERAPEUTICS, INC. (US) 2022-02-17 — — WO disclosed
Send feedback